Shania M Corry

Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer

D. Longley, P. Dunne, O. Sansom, 2022, Gut.

MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer

R. Sanz-Pamplona, P. Dunne, M. Lawler, 2022, bioRxiv.

Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data

P. Dunne, N. Jamieson, M. Lawler, 2022, bioRxiv.

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment.

P. Dunne, T. Ritter, A. Ryan, 2023, Cell reports.

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer

P. Dunne, C. Isella, L. Trusolino, 2024, Nature genetics.